Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Medicinal and recreational marijuana use among HIV-infected women in the Women's Interagency HIV Study (WIHS) cohort, 1994-2010.

Dʼsouza G, Matson PA, Grady CD, Nahvi S, Merenstein D, Weber KM, Greenblatt R, Burian P, Wilson TE.

J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):618-26. doi: 10.1097/QAI.0b013e318273ab3a.

2.

Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS).

Kuo WH, Wilson TE, Weber KM, Madhava V, Richardson J, Delapenha R, Des Jarlais D.

AIDS Patient Care STDS. 2004 Dec;18(12):702-13.

PMID:
15659881
3.

Medicinal and recreational marijuana use by patients infected with HIV.

Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R.

AIDS Patient Care STDS. 2004 Apr;18(4):215-28.

PMID:
15142352
4.

High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.

Slawson G, Milloy MJ, Balneaves L, Simo A, Guillemi S, Hogg R, Montaner J, Wood E, Kerr T.

AIDS Behav. 2015 Jan;19(1):120-7. doi: 10.1007/s10461-014-0847-3.

5.

Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.

Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L.

AIDS Patient Care STDS. 2014 Mar;28(3):136-43. doi: 10.1089/apc.2013.0329. Epub 2014 Feb 25.

6.

Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.

Hessol NA, Kalinowski A, Benning L, Mullen J, Young M, Palella F, Anastos K, Detels R, Cohen MH.

Clin Infect Dis. 2007 Jan 15;44(2):287-94. Epub 2006 Dec 12.

PMID:
17173233
7.

Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy.

Hanna DB, Jung M, Xue X, Anastos K, Cocohoba JM, Cohen MH, Golub ET, Hessol NA, Levine AM, Wilson TE, Young MA, Kaplan RC.

AIDS Patient Care STDS. 2016 Oct;30(10):445-454.

8.

Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.

Boodram B, Plankey MW, Cox C, Tien PC, Cohen MH, Anastos K, Karim R, Hyman C, Hershow RC.

AIDS Patient Care STDS. 2009 Dec;23(12):1009-16. doi: 10.1089/apc.2009.0175.

9.

Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.

Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE.

AIDS. 2007 Aug 20;21(13):1739-45.

PMID:
17690572
10.

Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.

Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, Levine AM.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1245-52.

PMID:
15385731
11.

Experience of pain among women with advanced HIV disease.

Richardson JL, Heikes B, Karim R, Weber K, Anastos K, Young M.

AIDS Patient Care STDS. 2009 Jul;23(7):503-11. doi: 10.1089/apc.2008.0128.

12.

Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women.

Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):377-83. doi: 10.1097/QAI.0b013e318160d552.

PMID:
18176324
13.

Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.

Telzak EE, Hershow R, Kalish LA, Hardy WD Jr, Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, Anastos K.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):513-8.

PMID:
9859966
14.

Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.

Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, Young M, Milam J, Cohen MH, Sharp GB, Huang Y, Greenblatt RM.

Clin Infect Dis. 2011 May;52(10):1267-75. doi: 10.1093/cid/cir131.

15.

Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea.

de Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM.

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):43-6.

PMID:
15608523
16.

Identifying HIV care enrollees at-risk for cannabis use disorder.

Hartzler B, Carlini BH, Newville H, Crane HM, Eron JJ, Geng EH, Mathews WC, Mayer KH, Moore RD, Mugavero MJ, Napravnik S, Rodriguez B, Donovan DM.

AIDS Care. 2017 Jul;29(7):846-850. doi: 10.1080/09540121.2016.1271393. Epub 2016 Dec 23.

PMID:
28006972
17.

Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study.

Hessol NA, Weber KM, D'Souza G, Burton D, Young M, Milam J, Murchison L, Gandhi M, Cohen MH.

Am J Prev Med. 2014 Jul;47(1):53-69. doi: 10.1016/j.amepre.2014.02.010. Epub 2014 Apr 18.

18.

Neuropsychological functioning in a cohort of HIV infected women: importance of antiretroviral therapy.

Richardson JL, Martin EM, Jimenez N, Danley K, Cohen M, Carson VL, Sinclair B, Racenstein JM, Reed RA, Levine AM.

J Int Neuropsychol Soc. 2002 Sep;8(6):781-93. Erratum in: J Int Neuropsychol Soc. 2005 Jan;11(1):120.

PMID:
12240742
19.

Marijuana as therapy for people living with HIV/AIDS: social and health aspects.

Fogarty A, Rawstorne P, Prestage G, Crawford J, Grierson J, Kippax S.

AIDS Care. 2007 Feb;19(2):295-301.

PMID:
17364413
20.

Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984-2013.

Okafor CN, Cook RL, Chen X, Surkan PJ, Becker JT, Shoptaw S, Martin E, Plankey MW.

Am J Drug Alcohol Abuse. 2017 Sep;43(5):556-566. doi: 10.1080/00952990.2016.1245738. Epub 2016 Nov 3.

Supplemental Content

Support Center